neoplasm
Showing NaN - NaN of 6
Cancer, Malignancy, Neoplasia Trial in United States (ASN007: ascending doses, ASN007 RD)
Completed
- Cancer
- +18 more
- ASN007: ascending doses
- ASN007 RD
-
Tampa, Florida
- +4 more
Jul 7, 2020
Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose
Terminated
- Lymphoma, Large B-Cell, Diffuse
- +20 more
- ASN002 Dose Escalation
- ASN002 RD
-
Tempe, Arizona
- +13 more
Aug 13, 2018
Tumor Trial in United States (Escalation cohort: Regorafenib (Stivarga, BAY73-4506) 20 mg, Escalation cohort: Regorafenib
Completed
- Neoplasm
- Escalation cohort: Regorafenib (Stivarga, BAY73-4506) 20 mg
- +7 more
-
Los Angeles, California
- +4 more
Nov 16, 2015
Carcinoma, Non-small-cell Lung, Metastases Trial in United States (ZD1839 (Gefitinib))
Completed
- Carcinoma
- +3 more
- ZD1839 (Gefitinib)
-
Alabaster, Alabama
- +626 more
Jan 3, 2013